中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 42 Issue 7
Jul.  2026
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2026  >  42(7): 1688-1697

Mechanism of action of flavonoids in the treatment of hepatic fibrosis and related signaling pathways

DOI: 10.12449/JCH260728

  • Department of Gastroenterology，The Affiliated Hospital of Yanbian University，Yanji，Jilin 133000，China

Research funding:

Natural Science Foundation Project of Jilin Provincial Department of Science and Technology (YDZJ202301ZYTS203);

Science and Technology Research Project of Jilin Provincial Department of Education (JJKH20191143KJ)

More Information
  • Corresponding author: Jin Zhezhu， jinzz1021@163.com （ORCID： 0009-0002-9591-1060）; Li Chenghao， jiaoyanshi08@163.com （ORCID： 0000-0002-9614-410X）
  • Received Date: 2025-11-19
  • Accepted Date: 2026-01-22
  • Published Date: 2026-07-25
    Abstract
  • The incidence rate of hepatic fibrosis remains at a high level， and there is still a lack of specific therapeutic drugs， posing a serious threat to human health. As a type of natural active components widely present in plants， flavonoids have multiple physiological functions such as antioxidant， anti-inflammatory， and anti-fibrotic activities， and a large number of studies have confirmed the anti-hepatic fibrosis effect of flavonoids. As for the mechanism of action， flavonoids can target the functions of hepatic stellate cells by inhibiting their proliferation and differentiation， promoting their apoptosis， regulating the level of autophagy， reducing the formation of extracellular matrix， and regulating iron metabolism in hepatic stellate cells， and meanwhile， they can inhibit chronic liver inflammatory response， improve oxidative stress status， regulate intestinal flora balance， and block epithelial-mesenchymal transition， thereby blocking the progression of fibrosis through multiple dimensions. At the level of signaling pathways， flavonoids mainly exert an anti-fibrotic effect by regulating the abnormal activation of the signaling pathways such as transforming growth factor-β1/Smad， Janus kinase/signal transducer and activator of transcription， nuclear factor erythroid 2-related factor 2， nuclear factor-kappa B， phosphatidylinositol 3-kinase/protein kinase B， mitogen-activated protein kinase， Wnt/β-catenin， and adenosine 5'-monophosphate-activated protein kinase. This article summarizes the research advances in the anti-fibrotic effect of flavonoids， in order to provide a theoretical basis for further exploring their medicinal potential.

     

    • FullText(HTML)
  • loading
    • References(49)
  • [1]
    Man S, Deng Y H, Ma Y, et al. Prevalence of liver steatosis and fibrosis in the general population and various high-risk populations: A nationwide study with 5.7 million adults in China[J]. Gastroenterology, 2023, 165( 4): 1025- 1040. DOI: 10.1053/j.gastro.2023.05.053.
    [2]
    Shi L Y, Zhang X L, Liu X, et al. Cranberry(Vacinium macrocarpon) phytochemicals inhibit hepatic stellate cell activation and liver fibrosis[J]. Food Biosci, 2021, 42: 101176. DOI: 10.1016/j.fbio.2021.101176.
    [3]
    Gao Xiaoyang, Zhao Xiaolu, Zhang Chunyan, et al. Quercetin induces hepatic stellate cell apoptosis by inhibiting the PI3K/Akt signaling pathway via upregulating miR-146[J]. J South Med Univ, 2023, 43( 10): 1725- 1733. DOI: 10.12122/j.issn.1673-4254.2023.10.10.

    高晓阳, 赵晓璐, 张春艳, 等. 槲皮素诱导肝星状细胞凋亡: 基于调控miR-146影响PI3K/Akt信号通路[J]. 南方医科大学学报, 2023, 43( 10): 1725- 1733. DOI: 10.12122/j.issn.1673-4254.2023.10.10.
    [4]
    Shi Mingliang, Wang Xiaolei, Li Jianglin, et al. Effect and mechanism of epigallocatechin gallate on activation of hepatic stellate cells based on Wnt signaling pathway[J]. Chin Tradit Herb Drugs, 2022, 53( 3): 758- 766. DOI: 10.7501/j.issn.0253-2670.2022.03.015.

    石明亮, 王晓磊, 李江琳, 等. 基于Wnt信号通路研究表没食子酸儿茶素没食子酸酯对肝星状细胞活化的作用及机制[J]. 中草药, 2022, 53( 3): 758- 766. DOI: 10.7501/j.issn.0253-2670.2022.03.015.
    [5]
    Huang Qian, Yang Yan, Zeng Rui, et al. Regulation of liver fibrosis by matrix metalloproteinase/tissue inhibitor of metalloproteinase and research advances in related therapeutic drugs[J]. J Clin Hepatol, 2022, 38( 6): 1420- 1425. DOI: 10.3969/j.issn.1001-5256.2022.06.042.

    黄倩, 杨燕, 曾锐, 等. 基质金属蛋白酶/基质金属蛋白酶水解酶对肝纤维化的调控及相关治疗药物研究进展[J]. 临床肝胆病杂志, 2022, 38( 6): 1420- 1425. DOI: 10.3969/j.issn.1001-5256.2022.06.042.
    [6]
    Zhang M M, Wang Y X, Zhu G N, et al. Hepatoprotective effect and possible mechanism of phytoestrogen calycosin on carbon tetrachloride-induced liver fibrosis in mice[J]. Naunyn Schmiedebergs Arch Pharmacol, 2021, 394( 1): 189- 204. DOI: 10.1007/s00210-020-01891-5.
    [7]
    Sabir U, Gu H M, Zhang D W. Extracellular matrix turnover: Phytochemicals target and modulate the dual role of matrix metalloproteinases(MMPs) in liver fibrosis[J]. Phytother Res, 2023, 37( 11): 4932- 4962. DOI: 10.1002/ptr.7959.
    [8]
    Han Zhiqiang, An Da, Deligen Batu. Effect of luteolin on TGF-β1 induced proliferation and apoptosis of HSC-T6 and α-SMA and collagen I secretion[J]. Chin J Gerontol, 2024, 44( 16): 3929- 3932. DOI: 10.3969/j.issn.1005-9202.2024.16.024.

    韩志强, 安达, 巴图德力根. 木犀草素对TGF-β1诱导HSC-T6增殖凋亡及分泌α-SMA、Collagen Ⅰ影响[J]. 中国老年学杂志, 2024, 44( 16): 3929- 3932. DOI: 10.3969/j.issn.1005-9202.2024.16.024.
    [9]
    Hu Xue. Acacetin improves liver fibrosis by mediating apoptosis through P53 pathway[D]. Chengdu: Chengdu Medical College, 2024.

    胡雪. 金合欢素通过P53通路介导凋亡改善肝纤维化[D]. 成都: 成都医学院, 2024.
    [10]
    Wu Lixia, Wang Yuwei, Wu Hongyan. Inhibitory effects of naringenin on the activation of hepatic stellate cells through activating the apoptosis signal[J]. China Pharm, 2023, 34( 10): 1187- 1192. DOI: 10.6039/j.issn.1001-0408.2023.10.07.

    吴丽霞, 王雨薇, 吴红雁. 柚皮素通过激活凋亡信号抑制肝星状细胞活化[J]. 中国药房, 2023, 34( 10): 1187- 1192. DOI: 10.6039/j.issn.1001-0408.2023.10.07.
    [11]
    Liu Xipeng, Zhang Meifang, Zhang Haifeng, et al. Role of PPAR-γ- regulated autophagy in genistein-induced inhibition of hepatic stellate cell activation[J]. J South Med Univ, 2019, 39( 5): 561- 565. DOI: 10.12122/j.issn.1673-4254.2019.05.10.

    刘希鹏, 张美芳, 张海峰, 等. PPAR-γ调控的自噬通路在染料木黄酮抑制肝星状细胞激活过程中的作用[J]. 南方医科大学学报, 2019, 39( 5): 561- 565. DOI: 10.12122/j.issn.1673-4254.2019.05.10.
    [12]
    Du Jinhui. Anthocyanins regulate the autophagy flux level of hepatic stellate cells through mmu＿circ＿0000623 to improve the mechanism of liver fibrosis in mice[D]. Guiyang: Guizhou Medical University, 2023.

    杜金辉. 花青素通过mmu＿circ＿0000623调控肝星状细胞自噬通量水平改善小鼠肝纤维化的机制研究[D]. 贵阳: 贵州医科大学, 2023.
    [13]
    Zhou Ruina, Wang Yang, Hu Jinhang, et al. Effect of total flavonoids from Astragali Complanati Semen on improving hepatic fibrosis in mice by regulating hepatic stellate cells iron metabolism[J]. Chin Tradit Herb Drugs, 2025, 56( 9): 3131- 3139. DOI: 10.7501/j.issn.0253-2670.2025.09.011.

    周瑞娜, 王洋, 胡锦航, 等. 沙苑子总黄酮通过调节肝星状细胞铁代谢改善小鼠肝纤维化[J]. 中草药, 2025, 56( 9): 3131- 3139. DOI: 10.7501/j.issn.0253-2670.2025.09.011.
    [14]
    Sima Ling. Study on the mechanism of action of total flavonoids from lychee nucleus on hepatic stellate cells based on iron deaths[D]. Nanning: Guangxi University of Chinese Medicine, 2024.

    司马玲. 基于铁死亡探讨荔枝核总黄酮对肝星状细胞作用机制研究[D]. 南宁: 广西中医药大学, 2024.
    [15]
    Kim D M, Pan Q, Liu Z Y, et al. GHSR-Foxo1 signaling in macrophages promotes liver fibrosis via inflammatory response and hepatic stellate cell activation[J]. Adv Sci, 2025, 12( 33): e04223. DOI: 10.1002/advs.202504223.
    [16]
    Li X, Jin Q W, Yao Q Y, et al. The flavonoid quercetin ameliorates liver inflammation and fibrosis by regulating hepatic macrophages activation and polarization in mice[J]. Front Pharmacol, 2018, 9: 72. DOI: 10.3389/fphar.2018.00072.
    [17]
    Wang J J, Jing X Z, Liu X Y, et al. Naringin safeguards vertebral endplate chondrocytes from apoptosis and NLRP3 inflammasome activation through SIRT3-mediated mitophagy[J]. Int Immunopharmacol, 2024, 140: 112801. DOI: 10.1016/j.intimp.2024.112801.
    [18]
    Zou Xiang, Mao Zhancun, Wang Xing. Effect and mechanism of baicalin on acute liver injury in mice[J]. J Pharm Res, 2025, 44( 8): 750- 755. DOI: 10.13506/j.cnki.jpr.2025.08.004.

    邹祥, 毛占存, 王星. 黄芩苷对小鼠急性肝损伤的作用及机制研究[J]. 药学研究, 2025, 44( 8): 750- 755. DOI: 10.13506/j.cnki.jpr.2025.08.004.
    [19]
    Niu Guanghao, Xu Junchi, Gu Liqing, et al. Protective effect of marein against alcoholic fatty liver and its mechanism[J]. China Pharm, 2024, 35( 9): 1044- 1049. DOI: 10.6039/j.issn.1001-0408.2024.09.04.

    牛广豪, 徐俊驰, 顾利青, 等. 马里苷对酒精性脂肪肝的保护作用及机制[J]. 中国药房, 2024, 35( 9): 1044- 1049. DOI: 10.6039/j.issn.1001-0408.2024.09.04.
    [20]
    Zhang X, Dong Z C, Fan H, et al. Scutellarin prevents acute alcohol-induced liver injury via inhibiting oxidative stress by regulating the Nrf2/HO-1 pathway and inhibiting inflammation by regulating the AKT, p38 MAPK/NF-κB pathways[J]. J Zhejiang Univ Sci B, 2023, 24( 7): 617- 631. DOI: 10.1631/jzus.B2200612.
    [21]
    Yinting Tuo, Hu Xinglan, Li Bocun, et al. Total flavonoids of Lizhihe(Lichi Semen)inhibiting hepatic inflammasome activation and alleviating hepatic fibrosis in rats[J]. Chin Arch Tradit Chin Med, 2026, 44( 2): 211- 214. DOI: 10.13193/j.issn.1673-7717.2026.02.036.

    陀银婷, 胡兴兰, 李泊村, 等. 荔枝核总黄酮抑制肝脏炎症小体活化并减轻大鼠肝纤维化[J]. 中华中医药学刊, 2026, 44( 2): 211- 214. DOI: 10.13193/j.issn.1673-7717.2026.02.036.
    [22]
    Lu L, Luan Y J, Wang H Q, et al. Flavonoid as a potent antioxidant: Quantitative structure-activity relationship analysis, mechanism study, and molecular design by synergizing molecular simulation and machine learning[J]. J Phys Chem A, 2024, 128( 30): 6216- 6228. DOI: 10.1021/acs.jpca.4c03241.
    [23]
    Zhou Jingkai, Weng Jingyu, Zhu Pan, et al. Effects of total flavonoids from Melastoma dodecandrum on weight loss and intestinal flora in rats fed with high-fat diets[J]. Chin Tradit Pat Med, 2021, 43( 10): 2673- 2678. DOI: 10.3969/j.issn.1001-1528.2021.10.012.

    周敬凯, 翁竞玉, 朱盼, 等. 地菍总黄酮对高脂饮食大鼠减肥作用及肠道菌群的影响[J]. 中成药, 2021, 43( 10): 2673- 2678. DOI: 10.3969/j.issn.1001-1528.2021.10.012.
    [24]
    Hu Xinglan, Yang Yingying, Huang Panling, et al. Total flavonoids from Litchi Semen alleviates carbon tetrachloride-induced hepatic fibrosis by restoring intestinal microbiota composition[J]. Chin Tradit Herb Drugs, 2025, 56( 1): 145- 153. DOI: 10.7501/j.issn.0253-2670.2025.01.015.

    胡兴兰, 杨莹莹, 黄盼玲, 等. 荔枝核总黄酮通过改善肠道菌群结构减轻四氯化碳诱发的肝纤维化[J]. 中草药, 2025, 56( 1): 145- 153. DOI: 10.7501/j.issn.0253-2670.2025.01.015.
    [25]
    Chen Jie. The mechanism of quercetin in improving liver fibrosis and EMT in Wilson disease was explored based on the hedgehog signaling pathway[D]. Hefei: Anhui University of Chinese Medicine, 2024.

    陈洁. 基于Hedgehog信号通路探究槲皮素改善Wilson病肝纤维化和EMT的机制研究[D]. 合肥: 安徽中医药大学, 2024.
    [26]
    Lin Yuancan, Luo Haiying, Liu Huifang, et al. Molecular mechanism of total flavonoids from Sedum sarmentosum intervening epithelial-mesenchymal transition of hepatic stellate cells through TGF-β_1/Smad2/3 pathway[J]. J Chin Med Mater, 2020, 43( 1): 202- 205.

    林远灿, 骆海莺, 刘慧芳, 等. 垂盆草总黄酮通过TGF-β_1/Smad2/3通路干预肝星状细胞上皮间质转化的分子机制[J]. 中药材, 2020, 43( 1): 202- 205.
    [27]
    Liu Yi. Exploring the mechanism of puerarin ameliorating liver fibrosis based on the regulation of TGF-β/smad/SOX4 signaling pathway[D]. Nanchang: Nanchang University, 2024.

    刘熠. 基于TGF-β/Smad/SOX4信号通路探究葛根素抗肝纤维化的作用机制[D]. 南昌: 南昌大学, 2024.
    [28]
    Hu Yixiang, Liu Renzhu, Guo Xiaolan, et al. Study on the effects of total flavonoids extracted from Acer ginnala Maxim on hepatic fibrosis in mice and its mechanism[J]. Northwest Pharm J, 2020, 35( 1): 67- 72. DOI: 10.3969/j.issn.1004-2407.2020.01.016.

    胡毅翔, 刘任祝, 郭小兰, 等. 茶条槭总黄酮提取物抗小鼠肝纤维化作用及其机制研究[J]. 西北药学杂志, 2020, 35( 1): 67- 72. DOI: 10.3969/j.issn.1004-2407.2020.01.016.
    [29]
    Ou Shiyu, Du Ling, Wei Jie, et al. Effects of total flavone from Litchi chinensis sonn on rats with hepatic fibrosis through JAK2/STAT3 signaling pathway[J]. Lab Med Clinic, 2022, 19( 23): 3216- 3219. DOI: 10.3969/j.issn.1672-9455.2022.23.013.

    欧士钰, 杜凌, 韦捷, 等. 荔枝核总黄酮通过JAK2/STAT3信号通路抗大鼠肝纤维化的实验研究[J]. 检验医学与临床, 2022, 19( 23): 3216- 3219. DOI: 10.3969/j.issn.1672-9455.2022.23.013.
    [30]
    Cao Houkang, Gao Ya, Huang Simao, et al. Research on mechanism of effect of total flavonoids extracted from Polygonum perfoliatum L. on anti-hepatic fibrosis in rats[J]. Chin Pharmacol Bull, 2017, 33( 9): 1303- 1308. DOI: 10.3969/j.issn.1001-1978.2017.09.022.

    曹后康, 高雅, 黄思茂, 等. 杠板归总黄酮抗大鼠肝纤维化作用的机制研究[J]. 中国药理学通报, 2017, 33( 9): 1303- 1308. DOI: 10.3969/j.issn.1001-1978.2017.09.022.
    [31]
    Gu Yufeng, Deng Bingying, Li Niren, et al. Mechanisms of total flavonoids from Sophora flavescens for the treatment of non-alcoholic fatiy liver disease and experimental validation in zebrafish[J]. Chin J Tissue Eng Res, 2025, 29( 14): 2969- 2978. DOI: 10.12307/2025.612.

    古玉凤, 邓丙英, 李倪仁, 等. 苦参总黄酮改善非酒精性脂肪肝的作用机制及斑马鱼实验验证[J]. 中国组织工程研究, 2025, 29( 14): 2969- 2978. DOI: 10.12307/2025.612.
    [32]
    Zhang Li, Fang Buwu. Inhibitory effects and mechanism of Polydatin on the proliferation and activation of hepatic stellate cell[J]. J Tianjin Med Univ, 2020, 26( 4): 309- 312.

    张丽, 方步武. 虎杖苷抑制肝星状细胞增殖活化的作用和机制研究[J]. 天津医科大学学报, 2020, 26( 4): 309- 312.
    [33]
    Guo Ziyu, Li Chenyang, Zuo Dijun, et al. Preventive effects of total flavonoids from Nymphaea candida on alcoholic liver injury in mice[J]. China Food Addit, 2023, 34( 4): 205- 211. DOI: 10.19804/j.issn1006-2513.2023.04.024.

    郭子雨, 李晨阳, 左递军, 等. 睡莲花总黄酮对小鼠酒精肝损伤的防治作用研究[J]. 中国食品添加剂, 2023, 34( 4): 205- 211. DOI: 10.19804/j.issn1006-2513.2023.04.024.
    [34]
    Wang Bingbing, Zhu Hua, Xu Liba, et al. Protective effects of chrysin on liver oxidative stress injury in rats[J]. West China J Pharm Sci, 2025, 40( 5): 536- 540. DOI: 10.13375/j.cnki.wcjps.2025.05.011.

    王冰冰, 朱华, 许立拔, 等. 白杨素对大鼠肝组织氧化应激损伤的保护作用[J]. 华西药学杂志, 2025, 40( 5): 536- 540. DOI: 10.13375/j.cnki.wcjps.2025.05.011.
    [35]
    Huang Q L, Huang L N, Zhao G Y, et al. Naringin attenuates Actinobacillus pleuropneumoniae-induced acute lung injury via MAPK/NF-κB and Keap1/Nrf2/HO-1 pathway[J]. BMC Vet Res, 2024, 20( 1): 204. DOI: 10.1186/s12917-024-04055-2.
    [36]
    Jaffar H M, Al-Asmari F, Khan F A, et al. Silymarin: Unveiling its pharmacological spectrum and therapeutic potential in liver diseases-a comprehensive narrative review[J]. Food Sci Nutr, 2024, 12( 5): 3097- 3111. DOI: 10.1002/fsn3.4010.
    [37]
    Zhang J L, Zhang H M, Deng X L, et al. Baicalin attenuates non-alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, inflammation and fibrosis in mice[J]. Life Sci, 2018, 192: 46- 54. DOI: 10.1016/j.lfs.2017.11.027.
    [38]
    Zaghloul R A, Zaghloul A M, El-Kashef D H. Hepatoprotective effect of Baicalin against thioacetamide-induced cirrhosis in rats: Targeting NOX4/NF-κB/NLRP3 inflammasome signaling pathways[J]. Life Sci, 2022, 295: 120410. DOI: 10.1016/j.lfs.2022.120410.
    [39]
    Li Mingqi, Wang Yinghe, Zhao Xiaolu, et al. Mechanism of total flavonoids of Carthamus tinctorius L.against hepatic fibrosis based on LC-MS/MS combined with network pharmacology and pharmacology experiments[J]. Chin J Clin Pharmacol Ther, 2025, 30( 5): 586- 598. DOI: 10.12092/j.issn.1009-2501.2025.05.002.

    李明奇, 王映荷, 赵晓璐, 等. 基于LC-MS/MS结合网络药理学、分子对接及体内外实验探究红花总黄酮抗肝纤维化的作用机制[J]. 中国临床药理学与治疗学, 2025, 30( 5): 586- 598. DOI: 10.12092/j.issn.1009-2501.2025.05.002.
    [40]
    Cai X T, Miao J, Sun R W, et al. Dihydroartemisinin overcomes the resistance to osimertinib in EGFR-mutant non-small-cell lung cancer[J]. Pharmacol Res, 2021, 170: 105701. DOI: 10.1016/j.phrs.2021.105701.
    [41]
    Shen M, Guo M, Wang Z Y, et al. ROS-dependent inhibition of the PI3K/Akt/mTOR signaling is required for Oroxylin A to exert anti-inflammatory activity in liver fibrosis[J]. Int Immunopharmacol, 2020, 85: 106637. DOI: 10.1016/j.intimp.2020.106637.
    [42]
    Wei Qiyuan, Zhuge Fang, Su Lianyu, et al. Study on the anti-CCl4 rat liver fibrosis mechanism of Xiangsiteng total flavonoid based on FAK/PI3K/Akt signaling pathway[J]. J Guangxi Med Univ, 2020, 37( 10): 1816- 1823. DOI: 10.16190/j.cnki.45-1211/r.2020.10.010.

    韦淇元, 诸葛芳, 粟莲玉, 等. 相思藤总黄酮基于FAK/PI3K/Akt信号通路抗CCl4大鼠肝纤维化作用机制的研究[J]. 广西医科大学学报, 2020, 37( 10): 1816- 1823. DOI: 10.16190/j.cnki.45-1211/r.2020.10.010.
    [43]
    Yu Z L, Jv Y, Cai L, et al. Gambogic acid attenuates liver fibrosis by inhibiting the PI3K/AKT and MAPK signaling pathways via inhibiting HSP90[J]. Toxicol Appl Pharmacol, 2019, 371: 63- 73. DOI: 10.1016/j.taap.2019.03.028.
    [44]
    Lin G, Li W B, Hong W B, et al. Spinosin inhibits activated hepatic stellate cell to attenuate liver fibrosis by targeting Nur77/ASK1/p38 MAPK signaling pathway[J]. Eur J Pharmacol, 2024, 966: 176270. DOI: 10.1016/j.ejphar.2023.176270.
    [45]
    He Jingjing, Zheng Ya, Ji Rui. Mechanism of the Wnt signaling pathway regulating hepatic fibrosis associated with metabolic dysfunction-associated fatty liver disease and its application prospects[J]. J Clin Hepatol, 2025, 41( 11): 2372- 2378. DOI: 10.12449/JCH251126.

    贺晶晶, 郑亚, 姬瑞. Wnt信号通路调控代谢相关脂肪性肝病肝纤维化的机制及临床应用前景[J]. 临床肝胆病杂志, 2025, 41( 11): 2372- 2378. DOI: 10.12449/JCH251126.
    [46]
    Chen Wenlong, Dai Fuzhen, Shao Zhengyong, et al. Inhibitory and protective effects of quercetin on hepatic fibrosis induced by carbon tetrachloride in rats[J]. Chin J Immunol, 2021, 37( 1): 46- 50. DOI: 10.3969/j.issn.1000-484X.2021.01.008.

    陈文龙, 戴富臻, 邵正勇, 等. 槲皮素对四氯化碳诱导的大鼠肝纤维化抑制作用和肝保护作用[J]. 中国免疫学杂志, 2021, 37( 1): 46- 50. DOI: 10.3969/j.issn.1000-484X.2021.01.008.
    [47]
    Hu J Y, Liu Y Y, Pan Z, et al. Eupatilin ameliorates hepatic fibrosis and hepatic stellate cell activation by suppressing β-catenin/PAI-1 pathway[J]. Int J Mol Sci, 2023, 24( 6): 5933. DOI: 10.3390/ijms24065933.
    [48]
    Zhang Yuxin, Guo Haolin, Li Jifeng, et al. Protective effect of chrysin regulates AMPK-NLRP3 signaling mediated pyroptosis to alleviate hepatic fibrosis[J]. Acta Pharm Sin, 2023, 58( 9): 2669- 2676. DOI: 10.16438/j.0513-4870.2022-1045.

    张宇欣, 郭浩林, 李纪丰, 等. 白杨素调控AMPK-NLRP3通路介导细胞焦亡对肝纤维化的保护作用[J]. 药学学报, 2023, 58( 9): 2669- 2676. DOI: 10.16438/j.0513-4870.2022-1045.
    [49]
    Jiang Hechun. Hesperetin derivative-16 attenuates CCl4-induced inflammation and liver fibrosis by activating AMPK/SIRT3 pathway[D]. Hefei: Anhui Medical University, 2022.

    江贺春. 橙皮素衍生物-16通过激活AMPK/SIRT3通路减轻CCl4诱导的炎症和肝纤维化[D]. 合肥: 安徽医科大学, 2022.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(2)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (63) PDF downloads(18) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return